β¨ Medicine Distribution Consents
26 MAY 2005 NEW ZEALAND GAZETTE, No. 83 1977
Schedule
Product:
Remicade
Active Ingredient:
Infliximab 100mg
Dosage Form:
Powder for infusion concentrate
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Parkedale Pharmaceuticals Inc, Rochester, Michigan, United States of America
Patheon Italia SpA, Stucchi, Monza, Italy
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Dated this 19th day of May 2005.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3204
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Bisacodyl
Active Ingredient:
Bisacodyl 10mg
Dosage Form:
Suppository
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
G & W Laboratories, South Plainfield, New Jersey, United States of America
Product:
Colgate Sensitive Cool Mint Toothpaste
Active Ingredients:
Potassium nitrate 5%w/w
Sodium monofluorophosphate 0.755%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer:
Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product:
Colgate Sensitive Fresh Stripe Whitening Toothpaste
Active Ingredients:
Potassium nitrate 5%w/w
Sodium monofluorophosphate 0.755%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer:
Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product:
Colgate Sensitive Whitening Toothpaste
Active Ingredients:
Potassium nitrate 5%w/w
Sodium monofluorophosphate 0.755%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer(s):
Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product:
Eligard
Active Ingredient:
Leuprorelin acetate 22.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Mayne Pharma Pty Limited
Manufacturers:
Atrix Laboratories Inc, Fort Collins, Colorado, United States of America
Chesapeake Biological Laboratories Inc., Baltimore, Maryland, United States of America
Product:
Eligard
Active Ingredient:
Leuprorelin acetate 30mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Mayne Pharma Pty Limited
Manufacturers:
Atrix Laboratories Inc, Fort Collins, Colorado, United States of America
Chesapeake Biological Laboratories Inc., Baltimore, Maryland, United States of America
Product:
Eligard
Active Ingredient:
Leuprorelin acetate 7.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Mayne Pharma Pty Limited
Manufacturers:
Atrix Laboratories Inc, Fort Collins, Colorado, United States of America
Chesapeake Biological Laboratories Inc., Baltimore, Maryland, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 83
Gazette.govt.nz —
NZ Gazette 2005, No 83
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of a Changed Medicine
(continued from previous page)
π₯ Health & Social Welfare19 May 2005
Medicines, Distribution Consent, Changed Medicine
- BARRY BORMAN, Acting Deputy Director-General, Public Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution Consent, New Medicines